Indivior Pharmaceuticals (INDV) Shares Outstanding (Weighted Average) (2021 - 2026)

Indivior Pharmaceuticals' Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $124.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $124.0 million; the TTM figure through Mar 2026 stood at $124.0 million (changed 0.0% YoY), while the FY2025 annual figure was $125.0 million, down 5.3% from the prior year.
• Shares Outstanding (Weighted Average) was $124.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $125.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $139.0 million in Q4 2022 to a low of $124.0 million in Q1 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $130.4 million across 5 years, with a median of $132.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) jumped 98.57% in 2022, then retreated 8.82% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $139.0 million in 2022, then slipped by 1.44% to $137.0 million in 2023, then dropped by 3.65% to $132.0 million in 2024, then slipped by 5.3% to $125.0 million in 2025, then dropped by 0.8% to $124.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $124.0 million (Q1 2026), $125.0 million (Q4 2025), and $125.0 million (Q3 2025), per Business Quant data.